# Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60

> **NCT02234037** · PHASE1 · TERMINATED · sponsor: **Emory University** · enrollment: 3 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** Decitabine
- **BEHAVIORAL:** Exercise

## Key facts

- **NCT ID:** NCT02234037
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2016-02
- **Final completion:** 2016-05
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2017-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02234037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02234037, "Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02234037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*